These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24975464)

  • 1. Structural and functional characterization of an anti-West Nile virus monoclonal antibody and its single-chain variant produced in glycoengineered plants.
    Lai H; He J; Hurtado J; Stahnke J; Fuchs A; Mehlhop E; Gorlatov S; Loos A; Diamond MS; Chen Q
    Plant Biotechnol J; 2014 Oct; 12(8):1098-107. PubMed ID: 24975464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and analysis of novel plant-derived antibody-based therapeutic molecules against West Nile virus.
    He J; Lai H; Engle M; Gorlatov S; Gruber C; Steinkellner H; Diamond MS; Chen Q
    PLoS One; 2014; 9(3):e93541. PubMed ID: 24675995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice.
    Lai H; Engle M; Fuchs A; Keller T; Johnson S; Gorlatov S; Diamond MS; Chen Q
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2419-24. PubMed ID: 20133644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions.
    Goo L; Debbink K; Kose N; Sapparapu G; Doyle MP; Wessel AW; Richner JM; Burgomaster KE; Larman BC; Dowd KA; Diamond MS; Crowe JE; Pierson TC
    Nat Microbiol; 2019 Jan; 4(1):71-77. PubMed ID: 30455471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Monoclonal Antibodies against NS1 Protein Protect against Lethal West Nile Virus Infection.
    Wessel AW; Doyle MP; Engdahl TB; Rodriguez J; Crowe JE; Diamond MS
    mBio; 2021 Oct; 12(5):e0244021. PubMed ID: 34634945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus.
    Oliphant T; Engle M; Nybakken GE; Doane C; Johnson S; Huang L; Gorlatov S; Mehlhop E; Marri A; Chung KM; Ebel GD; Kramer LD; Fremont DH; Diamond MS
    Nat Med; 2005 May; 11(5):522-30. PubMed ID: 15852016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step.
    Vogt MR; Moesker B; Goudsmit J; Jongeneelen M; Austin SK; Oliphant T; Nelson S; Pierson TC; Wilschut J; Throsby M; Diamond MS
    J Virol; 2009 Jul; 83(13):6494-507. PubMed ID: 19386704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular basis of antibody-mediated neutralization of West Nile virus.
    Oliphant T; Diamond MS
    Expert Opin Biol Ther; 2007 Jun; 7(6):885-92. PubMed ID: 17555373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human IgG subclasses: in vitro neutralization of and in vivo protection against West Nile virus.
    Hofmeister Y; Planitzer CB; Farcet MR; Teschner W; Butterweck HA; Weber A; Holzer GW; Kreil TR
    J Virol; 2011 Feb; 85(4):1896-9. PubMed ID: 21123389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically delivered antibody protects against West Nile virus.
    Pereboev A; Borisevich V; Tsuladze G; Shakhmatov M; Hudman D; Kazachinskaia E; Razumov I; Svyatchenko V; Loktev V; Yamshchikov V
    Antiviral Res; 2008 Jan; 77(1):6-13. PubMed ID: 17904654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.
    McAuley AJ; Torres M; Plante JA; Huang CY; Bente DA; Beasley DWC
    J Virol; 2016 May; 90(9):4757-4770. PubMed ID: 26912625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular basis of antibody protection against West Nile virus.
    Mehlhop E; Diamond MS
    Curr Top Microbiol Immunol; 2008; 317():125-53. PubMed ID: 17990792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A glycosylated peptide in the West Nile virus envelope protein is immunogenic during equine infection.
    Hobson-Peters J; Toye P; Sánchez MD; Bossart KN; Wang LF; Clark DC; Cheah WY; Hall RA
    J Gen Virol; 2008 Dec; 89(Pt 12):3063-3072. PubMed ID: 19008394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus.
    Dowd KA; Jost CA; Durbin AP; Whitehead SS; Pierson TC
    PLoS Pathog; 2011 Jun; 7(6):e1002111. PubMed ID: 21738473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice.
    Spohn G; Jennings GT; Martina BE; Keller I; Beck M; Pumpens P; Osterhaus AD; Bachmann MF
    Virol J; 2010 Jul; 7():146. PubMed ID: 20604940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Fc region of an antibody impacts the neutralization of West Nile viruses in different maturation states.
    Lee PD; Mukherjee S; Edeling MA; Dowd KA; Austin SK; Manhart CJ; Diamond MS; Fremont DH; Pierson TC
    J Virol; 2013 Dec; 87(24):13729-40. PubMed ID: 24109224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus.
    Throsby M; Geuijen C; Goudsmit J; Bakker AQ; Korimbocus J; Kramer RA; Clijsters-van der Horst M; de Jong M; Jongeneelen M; Thijsse S; Smit R; Visser TJ; Bijl N; Marissen WE; Loeb M; Kelvin DJ; Preiser W; ter Meulen J; de Kruif J
    J Virol; 2006 Jul; 80(14):6982-92. PubMed ID: 16809304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monoclonal antibody to DIII E protein allowing the differentiation of West Nile virus from other flaviviruses by a lateral flow assay.
    Rebollo B; Pérez T; Camuñas A; Pérez-Ramírez E; Llorente F; Sánchez-Seco MP; Jiménez-Clavero MÁ; Venteo Á
    J Virol Methods; 2018 Oct; 260():41-44. PubMed ID: 29958922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection with non-lethal West Nile virus Eg101 strain induces immunity that protects mice against the lethal West Nile virus NY99 strain.
    Kumar M; O'Connell M; Namekar M; Nerurkar VR
    Viruses; 2014 Jun; 6(6):2328-39. PubMed ID: 24915459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.